Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
64,094.22 +1,003.76 (+1.59%) CMC Crypto 200
1,350.71 -45.82 (-3.28%)
Aurora Spine Corporation (ASG.V)
| Previous close | 0.2750 |
| Open | 0.3000 |
| Bid | 0.2800 x 0 |
| Ask | 0.2950 x 0 |
| Day's range | 0.2900 - 0.3000 |
| 52-week range | 0.2300 - 0.4650 |
| Volume | |
| Avg. volume | 12,422 |
| Market cap | 21.945M |
| Beta (5Y monthly) | 0.64 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0400 |
| Earnings date | 29 Apr 2024 - 03 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireAurora Spine Corporation Celebrates Second Anniversary of Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device
CARLSBAD, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative spinal implants announced today that it has completed the second full year of implantation of the world’s first patient-bone-density matched interbody device, the cervical interbody DEXA-C. Trent Northcutt, CEO and President at Aurora Spine said, "It's a significant milestone for Aurora to celebrate the second anniversary of the
- GlobeNewswire
Aurora Spine’s Second Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent Office
CARLSBAD, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of its second United States Patent No: 11,850,162 entitled “Body Density Scan Result-Matched Orthopedic Implants and Methods of Use” for The World’s First DEXA Technology™ Patient-Matched Implant Technology. Aurora Spine’s first-of-its kind DEXA Techn
- GlobeNewswire
The United States Patent Office Grants New Patent for Aurora Spine’s Translucent GhostTube™ Surgical Operating Tube
CARLSBAD, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of its United States Patent No: 11,832,853 entitled “Hybrid Radiolucent Surgical Operating Tube”. Aurora Spine’s Ghost Tube™ was designed to provide superior anchoring with a translucent thermoplastic body and non-slipping titanium anchors to assure t
